Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Insights into Imaging
Published in: Insights into Imaging 2/2017

Open Access 01-04-2017 | Statement

Common strategic research agenda for radiation protection in medicine

Authors: European Association of Nuclear Medicine (EANM), European Federation of Organizations for Medical Physics (EFOMP), European Federation of Radiographer Societies (EFRS), European Society of Radiology (ESR), European Society for Radiotherapy and Oncology (ESTRO)

Published in: Insights into Imaging | Issue 2/2017

Login to get access

Abstract

Reflecting the change in funding strategies for European research projects, and the goal to jointly improve medical radiation protection through sustainable research efforts, five medical societies involved in the application of ionising radiation (European Association of Nuclear Medicine, EANM; European Federation of Organizations for Medical Physics. EFOMP; European Federation of Radiographer Societies, EFRS; European Society of Radiology, ESR; European Society for Radiotherapy and Oncology, ESTRO) have identified research areas of common interest and developed this first edition of the Common Strategic Research Agenda (SRA) for medical radiation protection.
The research topics considered necessary and most urgent for effective medical care and efficient in terms of radiation protection are summarised in five main themes:
1.
Measurement and quantification in the field of medical applications of ionising radiation
 
2.
Normal tissue reactions, radiation-induced morbidity and long-term health problems
 
3.
Optimisation of radiation exposure and harmonisation of practices
 
4.
Justification of the use of ionising radiation in medical practice
 
5.
Infrastructures for quality assurance
 
The SRA is a living document; thus comments and suggestions by all stakeholders in medical radiation protection are welcome and will be dealt with by the European Alliance for Medical Radiation Protection Research (EURAMED) established by the above-mentioned societies.

Main messages

• Overcome the fragmentation of medical radiation protection research in Europe
• Identify research areas of joint interest in the field of medical radiation protection
• Improve the use of ionising radiation in medicine
• Collect stakeholder feedback and seek consensus
• Emphasise importance of clinical translation and evaluation of research results
Literature
1.
Lassmann M, Chiesa C, Flux G, Bardiès M (2011) EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reporting. Eur J Nucl Med Mol Imaging 38:192–200CrossRefPubMed
2.
Stabin M, Xu XG (2014) Basic principles in the radiation dosimetry of nuclear medicine. Semin Nucl Med 44:162–171CrossRefPubMed
3.
4.
Gustafsson J, Brolin G, Cox M, Ljungberg M, Johansson L, Sjögreen GK (2015) Uncertainty propagation for SPECT/CT-based renal dosimetry in 177Lu peptide receptor radionuclide therapy. Phys Med Biol 60:8329CrossRefPubMed
5.
Spielmann V, Li WB, Zankl M, Oeh U, Hoeschen C (2016) Uncertainty quantification in internal dose calculations for seven selected radiopharmaceuticals. J Nucl Med 57(1):122–128
6.
Sarrut D, Bardiès M, Boussion N et al (2014) A review of the use and potential of the GATE Monte Carlo simulation code for radiation therapy and dosimetry applications. Med Phys 41:064301–0643015CrossRefPubMed
7.
Garcia M-P, Villoing D, McKay E et al (2015) TestDose: A nuclear medicine software based on Monte Carlo modeling for generating gamma camera acquisitions and dosimetry. Med Phys 42:6885–6894CrossRefPubMed
8.
D’Arienzo M, Capogni M, Smyth V et al (2014) Metrological issues in molecular radiotherapy. EPJ Web of Conf 77:00022CrossRef
9.
Sgouros G, Roeske JC, McDevitt MR et al (2010) MIRD pamphlet No. 22 (abridged): radiobiology and dosimetry of a-particle emitters for targeted radionuclide therapy. J Nucl Med 51:311–328CrossRefPubMed
10.
Xu XG (2014) An exponential growth of computational phantom research in radiation protection, imaging, and radiotherapy: a review of the fifty-year history. Phys Med Biol 59:R233CrossRefPubMedPubMedCentral
11.
Zanzonico P, Stabin MG (2014) Quantitative benefit-risk analysis of medical radiation exposures. Semin Nucl Med 44:210–214CrossRefPubMed
12.
Hardiansyah D, Maass C, Attarwala A, Müller B, Kletting P, Mottaghy FM et al (2016) The role of patient-based treatment planning in peptide receptor radionuclide therapy. Eur J Nucl Med Mol Imaging 43(5):871–880
13.
Kletting P, Kull T, Maaß C, et al. (2015) Optimized peptide amount and activity for Y-90-labeled DOTATATE therapy. J Nucl Med :503–508
14.
Kletting P, Schimmel S, Hänscheid H et al (2015) The NUKDOS software for treatment planning in molecular radiotherapy. Z Med Phys 25:264–274CrossRefPubMed
15.
Bardies M, Buvat I (2011) Dosimetry in nuclear medicine therapy: what are the specifics in image quantification for dosimetry? Q J Nucl Med Mol Imaging 55:5–20PubMed
16.
Pereira JM, Stabin MG, Lima FR, Guimaraes MI, Forrester JW (2010) Image quantification for radiation dose calculations—limitations and uncertainties. Health Phys 99:688–701CrossRefPubMedPubMedCentral
17.
Glatting G, Bardiès M, Lassmann M (2013) Treatment planning in molecular radiotherapy. Z Med Phys 23:262–269CrossRefPubMed
18.
Bardiès M, Flux G (2013) Defining the role for dosimetry and radiobiology in combination therapies. Eur J Nucl Med Mol Imaging 40:4–5CrossRefPubMed
19.
Pouget J-P, Navarro-Teulon I, Bardies M et al (2011) Clinical radioimmunotherapy—the role of radiobiology. Nat Rev Clin Oncol 8:720–734CrossRefPubMed
20.
Eberlein U, Scherthan H, Bluemel C, Peper M, Lapa C, Buck AK et al (2016) DNA damage in peripheral blood lymphocytes of thyroid cancer patients after radioiodine therapy. J Nucl Med 57(2):173–179
21.
Council of the European Union (2014) Council directive 2013/59/Euratom of 5 December 2013 laying down basic safety standards for protection against the dangers arising from exposure to ionising radiation, and repealing Directives 89/618/Euratom, 90/641/Euratom, 96/29/Euratom, 97/43/Euratom and 2003/122/Euratom. In: Official Journal of the European Union, 2014; 13
22.
Council of the European Union (2011) Council Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011 on the application of patients’ rights in cross-border healthcare. In: Official Journal of the European Union, 2011; 21.
23.
Nwankwo O, Mekdash H, Sihono D, Wenz F, Glatting G (2015) Knowledge-based radiation therapy (KBRT) treatment planning versus planning by experts: validation of a KBRT algorithm for prostate cancer treatment planning. Radiat Oncol 10:111CrossRefPubMedPubMedCentral
24.
Strigari L, Konijnenberg M, Chiesa C et al (2014) The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy. Eur J Nucl Med Mol Imaging 41:1976–1988CrossRefPubMed
25.
Glatting G, Lassmann M (2012) Developments in patient dosimetry for unsealed sources. In: Radiation Protection in Medicine: Setting the Scene for the Next Decade. Bonn: IAEA, 2012; 155–159.
26.
Dewaraja YK, Frey EC, Sgouros G et al (2012) MIRD pamphlet no. 23: quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapy. J Nucl Med 53:1310–1325CrossRefPubMedPubMedCentral
27.
European Commission (1996) European guidelines on quality criteria for diagnostic radiographic images. Office for Official Publications of the European Communities, Luxembourg
28.
Chen MY (2014) Radiation protection and regulations for the nuclear medicine physician. Semin Nucl Med 44:215–228CrossRefPubMed
29.
Remedios D, Drinkwater K, Warwick R, Clinical Radiology Audit Committee (CRAC) TRCoR, London (2014) National audit of appropriate imaging. Clin Radiol 69:1039–1044CrossRefPubMed
30.
Portelli J, McNulty J, Bezzina P, Rainford L (2016) Paediatric imaging radiation dose awareness and use of referral guidelines amongst radiology practitioners and radiographers. Insights Imaging 7(1):145–153CrossRefPubMed
31.
32.
Remedios D, Brink J, Holmberg O et al (2015) Clinical imaging guidelines part 1: a proposal for uniform methodology. J Am Coll Radiol 12:45–50CrossRefPubMed
33.
Bolch WE, Eckerman KF, Sgouros G, Thomas SR (2009) MIRD pamphlet No. 21: a generalized schema for radiopharmaceutical dosimetry—standardization of nomenclature. J Nucl Med 50:477–484CrossRefPubMed
34.
European Commission (2008) Radiation Protection No. 154. European Guidance on Estimating Population Doses from Medical X-Ray Procedures. Directorate-General for Energy and Transport
35.
European Commission (2008) Radiation Protection No. 159. Guidelines on clinical audit for medical radiological practices (diagnostic radiology, nuclear medicine and radiotherapy). Directorate-General for Energy and Transport
36.
ICRP (2009) Education and Training in Radiological Protection for Diagnostic and Interventional Procedures. In: Elsevier, ed. ICRP Publication 113. Oxford, UK: International Commission on Radiological Protection
37.
38.
European Commission (2014) C Radiation Protection No. 175. Guidelines on radiation protection education and training of medical professionals in the European Union. Directorate-General for Energy
39.
Del Guerra A, Bardies M, Belcari N et al (2013) Curriculum for education and training of medical physicists in nuclear medicine. Phys Med 29:139–162CrossRefPubMed
Metadata
Title
Common strategic research agenda for radiation protection in medicine
Authors
European Association of Nuclear Medicine (EANM)
European Federation of Organizations for Medical Physics (EFOMP)
European Federation of Radiographer Societies (EFRS)
European Society of Radiology (ESR)
European Society for Radiotherapy and Oncology (ESTRO)
Publication date
01-04-2017
Publisher
Springer Berlin Heidelberg
Published in
Insights into Imaging / Issue 2/2017
Electronic ISSN: 1869-4101
DOI
https://doi.org/10.1007/s13244-016-0538-x

Other articles of this Issue 2/2017

Insights into Imaging 2/2017 Go to the issue

Pictorial Review

“Unforgettable” – a pictorial essay on anatomy and pathology of the hippocampus

Pictorial Review

Central airway pathology: clinic features, CT findings with pathologic and virtual endoscopy correlation

Review

Radiological findings of unilateral tuberculous lung destruction

Review

Imaging of the ulcerated carotid atherosclerotic plaque: a review of the literature

Review

Utility of magnetic resonance imaging in the evaluation of left ventricular thickening

Pictorial Review

Gallbladder adenomyomatosis: imaging findings, tricks and pitfalls